Gilder Gagnon Howe & Co’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-48,545	Closed	-$389K	–	290
2022 Q1	$389K	Sell	48,545 -21,901	-31%	-$193K	﹤0.01%	275
2021 Q4	$820K	Sell	70,446 -360	-0.5%	-$4.31K	﹤0.01%	302
2021 Q3	$877K	Sell	70,806 -1,132	-2%	-$12.8K	﹤0.01%	325
2021 Q2	$882K	Buy	+71,938	New	+$882K	﹤0.01%	336

Other funds holding SLGC

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MAM

Madryn Asset Management New York $34.1M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gilder Gagnon Howe & Co's SLGC Position: Q2 2022 in Review

Gilder Gagnon Howe & Co sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q2 2022, closing a stake of 48,545 shares — an estimated $389K sold.

Gilder Gagnon Howe & Co first reported a position in SLGC in Q2 2021 and held it in 4 quarters. The position peaked at $882K in Q2 2021. 135 funds tracked by Wall St. Rank hold SLGC as of Q2 2022.

Gilder Gagnon Howe & Co reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 48,545 SomaLogic, Inc. Class A Common Stock shares in Q2 2022, an estimated $389K.
Gilder Gagnon Howe & Co first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2021 and held it in 4 quarters.
Gilder Gagnon Howe & Co's SomaLogic, Inc. Class A Common Stock position peaked at $882K in Q2 2021.
135 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q2 2022.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2022, filed 15 Aug 2022.